NCT06247826View on ClinicalTrials.gov

Mechanisms of Resistance to Amivantamab in Patients With NSCLC With EGFR Exon 20 Insertion

NARecruitingINTERVENTIONAL
Enrollment

30

Participants

Timeline

Start Date

January 15, 2024

Primary Completion Date

September 30, 2025

Study Completion Date

September 30, 2025

Conditions
Non-small Cell Lung CancerEGFR Exon 20 Insertion Mutation
Interventions
PROCEDURE

Blood sampling

Blood samples (2\*10 mL on ethylenediaminetetraacetic acid (EDTA)) will be taken at time of disease progression and will be sent for central liquid biopsy ctDNA analysis.

Trial Locations (18)

13915

RECRUITING

Oncologie thoracique Hôpital Nord, Marseille

21000

NOT_YET_RECRUITING

Oncologie, CLCC Dijon, Dijon

29200

RECRUITING

Centre Hospitalier du Morvan, Brest

33000

NOT_YET_RECRUITING

Oncologie Polyclinique Bordeaux Nord Aquitaine, Bordeaux

38043

RECRUITING

Pneumologie, CHU Grenoble, Grenoble

42055

RECRUITING

CHU Hôpital Nord, Saint-Etienne

56017

RECRUITING

CH Bretagne Atlantique, Vannes

64000

NOT_YET_RECRUITING

Pneumologie Centre Hospitalier, Pau

69100

NOT_YET_RECRUITING

Pneumologie, Hôpital Mutualiste Resamut, Villeurbanne

72000

NOT_YET_RECRUITING

Pneumologie CH, Le Mans

75005

NOT_YET_RECRUITING

Oncologie Institut Curie, Paris

75014

RECRUITING

Hôpital Cochin, Paris

75970

RECRUITING

Pneumologie, Hôpital Tenon, Paris

76031

RECRUITING

Hôpital Charles Nicolle, Rouen

94010

RECRUITING

Pneumologie Centre Hospitalier Intercommunal de Créteil, Créteil

97411

RECRUITING

CHU La Réunion Site Nord, Saint-Denis

06149

WITHDRAWN

Oncologie, Centre Antoine Lacassagne, Nice

02900

NOT_YET_RECRUITING

Pneumologie CHI Cornouaille, Quimper

All Listed Sponsors
lead

Groupe Francais De Pneumo-Cancerologie

OTHER